Reimbursement for cryoneurolysis with iovera° for OA Knee Pain
Monday, August 22nd, 2022 | 3:00 PM - 4:00 PM CT
iovera° is a novel handheld device that alleviates pain including osteoarthritis (OA) knee pain through a mechanism known as cryoneurolysis, which applies intensely focused cold therapy to a specific nerve to interrupt its ability to transmit a pain signal. Treatment with iovera° provides immediate non-opioid pain relief that can last up to 90 days, and in some cases longer, as the nerve regenerates over time.
Cryoneurolysis with iovera° for OA knee pain is eligible for reimbursement in hospital outpatient departments, ambulatory surgery centers and physician offices. This second installment of a 2-part webinar series reviews the eligible CPT codes, coding and billing associated with treating multiple nerves, and common reimbursement scenarios.
Webinar Learning Points:
Cryoneurolysis with iovera° for OA knee pain is eligible for reimbursement in hospital outpatient departments, ambulatory surgery centers and physician offices. This second installment of a 2-part webinar series reviews the eligible CPT codes, coding and billing associated with treating multiple nerves, and common reimbursement scenarios.
Webinar Learning Points:
- CPT Codes 64640 and 64624
- Clinical documentation checklist
- Coding and billing when treating multiple nerves (with and without ultrasound)
- Reimbursement scenarios across sites of care
For full indication and important Safety Information for iovera°, visit www.iovera.com/safety